Depression and diabetes: Treatment and health-care delivery

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 6, 2015, Pages 472-485

  Petrak, Frank ^a   Baumeister, Harald ^b   Skinner, Timothy C ^c   Brown, Alex ^d   Holt, Richard I G ^e  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c CHARLES DARWIN UNIVERSITY   (Australia)

^d SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; IMIPRAMINE; MAGNESIUM; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VITAMIN D; ANTIDIABETIC AGENT;

BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; CULTURAL ANTHROPOLOGY; DEPRESSION; DEVELOPING COUNTRY; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DSM-IV-TR; EVIDENCE BASED MEDICINE; GLYCEMIC CONTROL; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; PATIENT HEALTH QUESTIONNAIRE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SCREENING; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUICIDAL IDEATION; SUPPLEMENTATION; TREATMENT INDICATION; TREATMENT PLANNING; ADULT; AGED; COMORBIDITY; COOPERATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; MALE; MASS SCREENING; MIDDLE AGED; PSYCHOLOGY; PUBLIC RELATIONS; SOCIOECONOMICS; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; COMORBIDITY; COOPERATIVE BEHAVIOR; CULTURE; DELIVERY OF HEALTH CARE; DEPRESSION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INTERPROFESSIONAL RELATIONS; MALE; MASS SCREENING; MIDDLE AGED; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 84929956031     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00045-5     Document Type: Review

References (119)

1. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23:934-942.
2. Dirmaier J, Watzke B, Koch U, et al. Diabetes in primary care: prospective associations between depression, nonadherence and glycemic control. Psychother Psychosom 2010, 79:172-178.
3. De Groot M, Anderson R, Freedland K, Clouse R, Lustman P Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63:619-630.
4. Davydow DS, Russo JE, Ludman E, et al. The association of comorbid depression with intensive care unit admission in patients with diabetes: a prospective cohort study. Psychosomatics 2011, 52:117-126.
5. Hutter N, Schnurr A, Baumeister H Healthcare costs in patients with diabetes mellitus and comorbid mental disorders--a systematic review. Diabetologia 2010, 53:2470-2479.
6. Egede LE, Nietert PJ, Zheng D Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005, 28:1339-1345.
7. Richardson LK, Egede LE, Mueller M Effect of race/ethnicity and persistent recognition of depression on mortality in elderly men with type 2 diabetes and depression. Diabetes Care 2008, 31:880-881.
8. Bot M, Pouwer F, Zuidersma M, van Melle JP, de Jonge P Association of coexisting diabetes and depression with mortality after myocardial infarction. Diabetes Care 2012, 35:503-509.
9. Black SA, Markides KS, Ray LA Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003, 26:2822-2828.
10. Pan A, Lucas M, Sun Q, et al. Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatry 2011, 68:42-50.
11. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007, 370:851-858.
12. Baumeister H, Hutter N, Bengel J, Härter M Quality of life in medically ill persons with comorbid mental disorders: a systematic review and meta-analysis. Psychother Psychosom 2011, 80:275-286.
13. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 2006, 49:469-477.
14. Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 2008, 31:2398-2403.
15. Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004, 27:2154-2160.
16. Li C, Ford ES, Zhao G, Ahluwalia IB, Pearson WS, Mokdad AH Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the Behavioral Risk Factor Surveillance System, 2006. Diabetes Res Clin Pract 2009, 83:268-279.
17. Katon W, Simon G, Russo J, et al. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care 2004, 42:1222-1229.
18. Fisher L, Gonzalez JS, Polonsky WH The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med 2014, 31:764-772.
19. Snoek F, Bremmer M, Hermanns N Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes Endocrinol 2015, published online May 18. http://dx.doi.org/10.1016/S2213-8587(15)00135-7.
20. Baumeister H, Hutter N, Bengel J Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database Syst Rev 2012, 12. CD008381.
21. Global guidelines for type 2 diabetes IDF Clinical Guidelines Task Force, (accessed Nov 12, 2014). http://www.idf.org/sites/default/files/IDF-Guideline-for-Type-2-Diabetes.pdf.
22. Petrak F, Herpertz S, Albus C, Hirsch A, Kulzer B, Kruse J Psychosocial factors and diabetes mellitus: evidence-based treatment guidelines. Curr Diabetes Rev 2005, 1:255-270.
23. American diabetes association executive summary: standards of medical care in diabetes-2014. Diabetes Care 2014, 37:S5-13.
24. Common mental health disorders: identification and pathways to care CG123 2011, National collaborating centre for mental health, National Institute of Health and Clinical Excellence, London.
25. Kulzer B, Albus C, Herpertz S, et al. [Psychosocial aspects of diabetes mellitus (Part 2) S2-guideline psychosocial aspects of diabetes-long version]. Diabetologie 2013, 8:292-324. (in German).
26. Twist K, Stahl D, Amiel SA, Thomas S, Winkley K, Ismail K Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design. Psychosom Med 2013, 75:791-797.
27. Roy T, Lloyd CE, Pouwer F, Holt RIG, Sartorius N Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review. Diabet Med 2012, 29:164-175.
28. First MB, Williams JBW, Spitzer RL, Gibbon M Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT) 2007, Biometrics Research, New York State Psychiatric Institute, New York.
29. Wing JK, Babor T, Brugha T, et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990, 47:589-593.
30. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
31. Beck AT, Steer RA, Brown GK Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio.
32. Radloff LS The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
33. Zigmond AS, Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
34. Spitzer RL, Kroenke K, Williams JB Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999, 282:1737-1744.
35. McHale M, Hendrikz J, Dann F, Kenardy J Screening for depression in patients with diabetes mellitus. Psychosom Med 2008, 70:869-874.
36. Stahl D, Sum CF, Lum SS, et al. Screening for depressive symptoms: validation of the center for epidemiologic studies depression scale (CES-D) in a multiethnic group of patients with diabetes in Singapore. Diabetes Care 2008, 31:1118-1119.
37. Holt RI, van der Feltz-Cornelis CM Key concepts in screening for depression in people with diabetes. J Affect Disord 2012, 142:S72-S79.
38. Kroenke K, Spitzer RL, Williams JB, Lowe B The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 2010, 32:345-359.
39. van Steenbergen-Weijenburg KM, Vroege Ld, Ploeger RR, et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res 2010, 10:235.
40. Gilbody S, Sheldon T, Wessely S Should we screen for depression?. BMJ 2006, 332:1027-1030.
41. Gilbody S, Sheldon T, House A Screening and case-finding instruments for depression: a meta-analysis. CMAJ 2008, 178:997-1003.
42. Hermanns N, Caputo S, Dzida G, Khunti K, Meneghini LF, Snoek F Screening, evaluation and management of depression in people with diabetes in primary care. Prim Care Diabetes 2013, 7:1-10.
43. Pouwer F, Tack CJ, Geelhoed-Duijvestijn PH, et al. Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: a randomised controlled trial. Diabetologia 2011, 54:741-748.
44. Scollan-Koliopoulos M, Herrera I, Romano K, Gregory C, Rapp K, Bleich D Healthcare technician delivered screening of adults with diabetes to improve primary care provider recognition of depression. J Family Med Prim Care 2012, 1:97-102.
45. Hayashino Y, Suzuki H, Yamazaki K, Izumi K, Noda M, Kobayashi M Depressive symptoms, not completing a depression screening questionnaire, and risk of poor compliance with regular primary care visits in patients with type 2 diabetes: the Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) study group. Exp Clin Endocrinol Diabetes 2011, 119:276-280.
46. Fleer J, Tovote KA, Keers JC, et al. Screening for depression and diabetes-related distress in a diabetes outpatient clinic. Diabet Med 2013, 30:88-94.
47. Schierhout G, Nagel T, Si D, Connors C, Brown A, Bailie R Do competing demands of physical illness in type 2 diabetes influence depression screening, documentation and management in primary care: a cross-sectional analytic study in Aboriginal and Torres Strait Islander primary health care settings. Int J Ment Health Syst 2013, 7:16.
48. Alderson SL, Russell AM, McLintock K, Potrata B, House A, Foy R Incentivised case finding for depression in patients with chronic heart disease and diabetes in primary care: an ethnographic study. BMJ Open 2014, 4:e005146.
49. Simon GE Evidence review: efficacy and effectiveness of antidepressant treatment in primary care. Gen Hosp Psychiatry 2002, 24(4):213-224.
50. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme UK National Screening Committee, (accessed Nov 30, 2014). http://www.publications.parliament.uk/pa/cm201415/cmselect/cmsctech/244/24410.htm.
51. Ell K, Katon W, Xie B, et al. Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diabetes Care 2010, 33:706-713.
52. Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010, 363:2611-2620.
53. Polonsky W, Anderson B, Lohrer P, et al. Assessment of diabetes-related distress. Diabetes Care 1995, 18:754-760.
54. Bech P Measuring the dimension of Psychological General Well-being by the WHO-5 119. Quality of Life newsletter 2004, 15-16.
55. Lowe B, Kroenke K, Grafe K Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 2005, 58:163-171.
56. Whooley MA, Avins AL, Miranda J, Browner WS Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997, 12:439-445.
57. Li C, Ford ES, Strine TW, Mokdad AH Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care 2008, 31:105-107.
58. Cuijpers P, van Straten A, Smit F, Mihalopoulos C, Beekman A Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions. Am J Psychiatry 2008, 165:1272-1280.
59. Rodgers M, Asaria M, Walker S, et al. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review. Health Technol Assess 2012, 16:1-130.
60. Kampling H, Baumeister H, Jäckel WH, Mittag O Prevention of depression in chronically physically ill adults (protocol). Cochrane Database Syst Rev 2014, 8. CD011246.
61. Moulton CD, Pickup JC, Ismail K The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol 2015, published online May 18. http://dx.doi.org/10.1016/S2213-8587(15)00134-5.
62. Petrak F, Herpertz S Treatment of depression in diabetes: an update. Curr Opin Psychiatry 2009, 22:211-217.
63. Kulzer B, Albus C, Herpertz S, et al. [Pychosocial aspects of diabetes mellitus (part 1) S2-guideline psychosocial aspects of diabetes-long version]. Diabetologie 2013, 8:198-242. (in German).
64. American Diabetes Association. Standards of Medical Care in Diabetes-2014. Diabetes Care 37: 14-80.
65. Baumeister H, Hutter N Collaborative care for depression in medically ill patients. Curr Opin Psychiatry 2012, 25:405-414.
66. Baumeister H, Hutter N, Bengel J Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review. Diabet Med 2014, 31:773-786.
67. van der Feltz-Cornelis CM, Nuyen J, Stoop C, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 2010, 32:380-395.
68. Atlantis E, Fahey P, Foster J Collaborative care for comorbid depression and diabetes: a systematic review and meta-analysis. BMJ Open 2014, 4:e004706.
69. Huffman JC, Niazi SK, Rundell JR, Sharpe M, Katon WJ Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings: a publication by the Academy of Psychosomatic Medicine Research and Evidence-Based Practice Committee. Psychosomatics 2014, 55:109-122.
70. Lamers F, Jonkers CCM, Bosma H, et al. A minimal psychological intervention in chronically ill elderly patients with depression: a randomized trial. Psychother Psychosom 2010, 79:217-226.
71. Huang X, Song L, Li T Effect of health education and psychosocial intervention on depression in patients with type 2 diabetes. Zhongguo-xinli-weisheng-zazhi She 2002, 16:149-151.
72. Li S, Li M, Song S The effect of psychological intervention in treating diabetic patients with negative emotion. Shandong Arc Psychiatry 2003, 16:147-148.
73. Lu X, Lu B, Gu X Cognitive therapy in combination with electromyographic feedback in treatment of diabetes patients with depression after cerebral infarction. Chinese J Clin Psychol 2005, 13:215-216.
74. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998, 129:613-621.
75. Nobis S, Lehr D, Ebert DD, et al. Efficacy of a web-based intervention with mobile phone support in treating depressive symptoms in adults with type 1 and type 2 diabetes mellitus: a randomized controlled trial. Diabetes Care 2015, in press.
76. Penckofer SM, Ferrans C, Mumby P, et al. A psychoeducational intervention (SWEEP) for depressed women with diabetes. Ann Behav Med 2012, 44:192-206.
77. Piette JD, Richardson C, Himle J, et al. A randomized trial of telephonic counseling plus walking for depressed diabetes patients. Med Care 2011, 49:641-648.
78. Safren SA, Gonzalez JS, Wexler DJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care 2014, 37:625-633.
79. Simson U, Nawarotzky U, Friese G, et al. Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome. Diabet Med 2008, 25:206-212.
80. Tovote KA, Fleer J, Snippe E, et al. Individual mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with diabetes: results of a randomized controlled trial. Diabetes Care 2014, 37:2427-2434.
81. van Bastelaar KM, Pouwer F, Cuijpers P, Riper H, Snoek FJ Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 2011, 34:320-325.
82. Petrak F, Herpertz S, Albus C, et al. Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes mellitus. The Diabetes and Depression (DAD) study-a randomized controlled multicenter trial. Diabetes Care; in press.
83. Echeverry D, Duran P, Bonds C, Lee M, Davidson MB Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2009, 32:2156-2160.
84. Komorousova J, Beran J, Rusavy Z, Jankovec Z Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1. Neuro Endocrinol Lett 2010, 31:801-806.
85. Lustman PJ, Griffith LS, Clouse RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997, 59:241-250.
86. Lustman PJ, Griffith LS, Freedland KE, Clouse RE Fluoxetin for depression in diabetes: a randomized doubleblind placebo-controlled trial. Diabetes Care 2000, 23:618-623.
87. Paile-Hyvärinen M, Wahlbeck K, Eriksson JG Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine-a single-blind randomized placebo controlled trial. BMC Fam Pract 2003, 4:7.
88. Paile-Hyvärinen M, Wahlbeck K, Eriksson J Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine- a double-blind randomised placebo controlled 6-month trial. BMC Fam Pract 2007, 8:34.
89. Qu W, Meng P Relationship between blood glucose levels in patients with type 2 diabetes mellitus. Depression and anxiety and the ant-depression/anxiety intervention. Zhongguo Linchuang Kangfu 2005, 9:213-215.
90. Xue H Paroxetine for depression in diabetes: a randomized controlled trial. Zhongguo-xinli-weisheng-zazhi She 2004, 18:735-737.
91. Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res 2008, 21:218-223.
92. Gülseren L, Gülseren S, Hekimsoy Z, Mete L Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients. Arch Med Res 2005, 36:159-165.
93. Khazaie H, Rahimi M, Tatari F, Rezaei M, Najafi F, Tahmasian M Treatment of depression in type 2 diabetes with fluoxetine or citalopram?. Neurosciences (Riyadh) 2011, 16:42-45.
94. Bogner HR, de Vries HF Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial. Diabetes Educ 2010, 36:284-292.
95. Bogner HR, Morales KH, de Vries HF, Cappola AR Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Ann Fam Med 2012, 10:15-22.
96. Katon WJ, Von Korff M, Lin EH, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004, 61:1042-1049.
97. Williams JW, Katon W, Lin EH, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004, 140:1015-1024.
98. Deeks JJ, Higgins JP Statistical algorithms in Review Manager 5 (accessed Nov 30, 2014). http://www.cochrane.org/sites/default/files/uploads/handbook/Statistical_Methods_in_RevMan5-1.pdf.
99. Barnard K, Peveler RC, Holt RI Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review. Diabetes Care 2013, 36:3337-3345.
100. Jonkers CC, Lamers F, Evers SM, Bosma H, Metsemakers JF, van Eijk JT Economic evaluation of a minimal psychological intervention in chronically ill elderly patients with minor or mild to moderate depression: a randomized trial (the DELTA-study). Int J Technol Assess Health Care 2009, 25:497-504.
101. Katon W, Unutzer J, Fan M-Y, et al. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 2006, 29:265-270.
102. Hay JW, Katon WJ, Ell K, Lee PJ, Guterman JJ Cost-effectiveness analysis of collaborative care management of major depression among low-income, predominantly Hispanics with diabetes. Value Health 2012, 15:249-254.
103. Simon GE, Katon WJ, Lin EHB, et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry 2007, 64:65-72.
104. Petrak F, Hautzinger M, Plack K, et al. Cognitive behavioural therapy in elderly type 2 diabetes patients with minor depression or mild major depression: study protocol of a randomized controlled trial (MIND-DIA). BMC Geriatr 2010, 10:21.
105. Baumeister H, Parker G Meta-review of depressive subtyping models. J Affect Disord 2012, 139:126-140.
106. Baumeister H, Nowoczin L, Lin J, et al. Impact of an acceptance facilitating intervention on diabetes patients' acceptance of internet-based interventions for depression: a randomized controlled trial. Diabetes Res Clin Pract 2014, 105:30-39.
107. Kohler O, Benros ME, Nordentoft M, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 2014, 71:1381-1391.
108. Tabas I, Glass CK Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science (New York, NY) 2013, 339:166-172.
109. Sarris J, O'Neil A, Coulson CE, Schweitzer I, Berk M Lifestyle medicine for depression. BMC Psychiatry 2014, 14:107.
110. IDF Diabetes Atlas Sixth Edition Poster Update 2014 International Diabetes Federation (IDF), (accessed April 15, 2015). http://www.idf.org/diabetesatlas/update-2014.
111. Rotella F, Mannucci E Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry 2013, 74:31-37.
112. Patel V, Kleinman A Poverty and common mental disorders in developing countries. Bull World Health Organ 2003, 81:609-615.
113. Minges KE, Zimmet P, Magliano DJ, Dunstan DW, Brown A, Shaw JE Diabetes prevalence and determinants in Indigenous Australian populations: a systematic review. Diabetes Res Clin Pract 2011, 93:139-149.
114. Grace BS, Clayton P, McDonald SP Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy. Nephrology (Carlton) 2012, 17:76-84.
115. Australian Bureau of Statistics. Framework for measuring wellbeing: Aboriginal and Torres Strait islander peoples. 2010; cat. no. 4703.0., ABS, Canberra, Australia.
116. Davis W, Hunt K, Skinner TC, et al. Prevalence and associates of depression in Aboriginal vs Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study Phase II. OP-0643. World Diabetes Congress; 2-6 Dec, 2013; Melbourne, Australia; 2013.
117. NICE guidelines [CG91] Depression in adults with a chronic physical health problem: treatment and management National Institute for Health and Care Excellence (NICE), (accessed Nov 30, 2014). http://www.nice.org.uk/guidance/cg91/evidence/cg91-depression-with-a-chronic-physical-health-problem-full-guideline2.
118. Association AD Standards of medical care in diabetes-2014. Diabetes Care 2014, 37:S14-S80.
119. Bundesärztekammerl (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Therapie des Typ-2-Diabetes - Langfassung, Version 4. 2013, zuletzt geändert: November 2014. (accessed April 15, 2015).